Cargando...

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

BACKGROUND: In the recent phase III trial MPACT the combination of gemcitabine and nab-paclitaxel (Gem/NabP) showed increased overall survival compared to gemcitabine alone in the treatment of advanced pancreatic ductal adenocarcinoma (aPDA). Until now there has been limited information on the clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Blomstrand, Hakon, Scheibling, Ursula, Bratthäll, Charlotte, Green, Henrik, Elander, Nils O.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325739/
https://ncbi.nlm.nih.gov/pubmed/30621618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5244-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!